Pharmacokinetic properties of BAY 81‐8973, a full‐length recombinant factor VIII

Abstract

Results of the LEOPOLD trials show that the BAY 81-8973 pharmacokinetic profile is non-inferior to rFVIII-FS. Similar BAY 81-8973 pharmacokinetic values were observed following single and repeated dosing and across ethnic groups.